ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BMY Bristol Myers Squibb Co

43.99
0.29 (0.66%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Bristol Myers Squibb Co NYSE:BMY NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.29 0.66% 43.99 44.33 43.685 43.93 12,104,157 01:00:00

Bristol-Myers Squibb to Announce Results for Second Quarter 2019 on July 25, 2019

06/06/2019 11:59am

Business Wire


Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Bristol Myers Squibb Charts.

Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the second quarter of 2019 on Thursday, July 25, 2019. During a conference call at 10:30 a.m. ET on July 25, company executives will review financial information and will address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing in the U.S. toll free 888-254-3590 or international 323-994-2093, confirmation code: 9333832. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 1:45 p.m. ET on July 25 through 1:45 p.m. ET on August 8, 2019. The replay will also be available through http://investor.bms.com or by dialing in the U.S. toll free 888-203-1112 or international 719-457-0820, confirmation code: 9333832.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

Bristol-Myers Squibb CompanyMedia: Carrie Fernandez, 609-252-5222, carrie.fernandez@bms.comInvestors: John Elicker, 609-252-4611, john.elicker@bms.com, Tim Power 609-252-7509 timothy.power@bms.com

1 Year Bristol Myers Squibb Chart

1 Year Bristol Myers Squibb Chart

1 Month Bristol Myers Squibb Chart

1 Month Bristol Myers Squibb Chart

Your Recent History

Delayed Upgrade Clock